Edmond DE Rothschild Holding S.A. Raises Stock Position in Colgate-Palmolive Company $CL

Key Points

• Edmond DE Rothschild Holding S.A. increased its stake in Colgate-Palmolive Company by 7.2%, owning a total of 49,240 shares valued at approximately $4.6 million.
• Colgate-Palmolive's recent earnings report showed a profit of $0.92 per share, surpassing analysts' expectations of $0.89.
• The company announced a quarterly dividend of $0.52 per share, yielding 2.5% annually, with a payout ratio of 58.43%.

Edmond DE Rothschild Holding S.A. increased its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 7.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 49,240 shares of the company's stock after purchasing an additional 3,309 shares during the quarter. Edmond DE Rothschild Holding S.A.'s holdings in Colgate-Palmolive were worth $4,614,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Clark Capital Management Group Inc. boosted its holdings in Colgate-Palmolive by 23.0% in the first quarter. Clark Capital Management Group Inc. now owns 36,932 shares of the company's stock worth $3,461,000 after purchasing an additional 6,903 shares during the last quarter. Banque Transatlantique SA boosted its holdings in Colgate-Palmolive by 3,509.0% in the first quarter. Banque Transatlantique SA now owns 8,842 shares of the company's stock worth $766,000 after purchasing an additional 8,597 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in Colgate-Palmolive by 60.5% in the first quarter. Alliancebernstein L.P. now owns 2,336,783 shares of the company's stock worth $218,957,000 after purchasing an additional 880,527 shares during the last quarter. Advisors Asset Management Inc. boosted its holdings in Colgate-Palmolive by 12.9% in the first quarter. Advisors Asset Management Inc. now owns 88,579 shares of the company's stock worth $8,300,000 after purchasing an additional 10,105 shares during the last quarter. Finally, Aprio Wealth Management LLC boosted its holdings in Colgate-Palmolive by 88.3% in the first quarter. Aprio Wealth Management LLC now owns 5,784 shares of the company's stock worth $542,000 after purchasing an additional 2,713 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 0.2%

CL opened at $83.67 on Friday. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. Colgate-Palmolive Company has a fifty-two week low of $82.40 and a fifty-two week high of $109.30. The firm's fifty day moving average is $86.82 and its 200 day moving average is $89.75. The stock has a market cap of $67.62 billion, a price-to-earnings ratio of 23.50, a price-to-earnings-growth ratio of 4.36 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion for the quarter, compared to analysts' expectations of $5.03 billion. During the same quarter in the previous year, the company earned $0.91 EPS. Colgate-Palmolive's revenue for the quarter was up 1.0% on a year-over-year basis. On average, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were paid a dividend of $0.52 per share. The ex-dividend date was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive's payout ratio is 58.43%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CL shares. Citigroup dropped their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, August 4th. UBS Group dropped their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research note on Thursday, July 17th. Morgan Stanley dropped their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday, August 4th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $98.92.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.